Global Observational Cohort Study on the Prediction of Unwanted Adverse Effects in Individuals Infected with Chronic Hepatitis C Receiving a Long-Acting Interferon plus Ribavirin (GUARD-C)

Title

Description

A. Verhaz, Global Observational Cohort Study on the Prediction of Unwanted Adverse Effects in Individuals Infected with Chronic Hepatitis C Receiving a Long-Acting Interferon plus Ribavirin (GUARD-C), pegylated interferon (RO0258310) Roche Clinical Study Report - Protocol MV22255 - Research Report 1060779, 2014.

Identifier

/unibl/sci/idNaucniRad:17180

Type

See all items with this valueArticle

See all items with this valuetext

Date

See all items with this value2014

Bibliographic Citation

A. Verhaz, Global Observational Cohort Study on the Prediction of Unwanted Adverse Effects in Individuals Infected with Chronic Hepatitis C Receiving a Long-Acting Interferon plus Ribavirin (GUARD-C), pegylated interferon (RO0258310) Roche Clinical Study Report - Protocol MV22255 - Research Report 1060779, 2014

Publisher

pegylated interferon (RO0258310) Roche Clinical Study Report - Protocol MV22255 - Research Report 1060779

list of authors

See all items with this value Antonija Verhaz

Relation

See all items with this value Medicinski fakultet